Zepp Health Corporation
ZEPP
$2.53
-$0.13-4.89%
NYSE
| 12/31/2024 | 09/30/2024 | 03/31/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 59.54M | 42.46M | 40.01M | 40.01M | 83.01M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 59.54M | 42.46M | 40.01M | 40.01M | 83.01M |
| Cost of Revenue | 37.61M | 25.22M | 25.29M | 25.29M | 54.17M |
| Gross Profit | 21.93M | 17.24M | 14.72M | 14.72M | 28.83M |
| SG&A Expenses | 19.81M | 18.92M | 17.17M | 17.17M | 17.08M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 68.48M | 55.00M | 55.85M | 55.85M | 82.38M |
| Operating Income | -8.94M | -12.54M | -15.84M | -15.84M | 626.00K |
| Income Before Tax | -23.33M | -13.26M | -14.66M | -14.66M | 1.51M |
| Income Tax Expenses | 13.57M | -- | 71.60K | 71.60K | 2.78M |
| Earnings from Continuing Operations | -36.90M | -13.26M | -14.73M | -14.73M | -1.26M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 25.00K | 8.00K | 32.20K | 32.20K | -15.00K |
| Net Income | -36.88M | -13.25M | -14.70M | -14.70M | -1.28M |
| EBIT | -8.94M | -12.54M | -15.84M | -15.84M | 626.00K |
| EBITDA | -7.68M | -10.60M | -13.95M | -13.95M | 2.55M |
| EPS Basic | -36.70 | -13.13 | -14.50 | -14.50 | -1.36 |
| Normalized Basic EPS | -0.51 | -0.52 | -0.64 | -0.64 | 0.10 |
| EPS Diluted | -36.70 | -13.13 | -14.62 | -14.62 | -2.51 |
| Normalized Diluted EPS | -0.51 | -0.52 | -0.64 | -0.64 | 0.10 |
| Average Basic Shares Outstanding | 16.08M | 16.15M | 16.22M | 16.22M | 15.09M |
| Average Diluted Shares Outstanding | 1.00M | 1.01M | 1.01M | 1.01M | 943.30K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |